Postnatal Zika and Dengue Infection and their Effects on Neurodevelopment Among Children Living in Rural Guatemala.
Autor: | Asturias EJ; From the Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado.; Center for Global Health or Department of Epidemiology, Colorado School of Public Health, Aurora, Colorado., Connery AK; Center for Global Health or Department of Epidemiology, Colorado School of Public Health, Aurora, Colorado.; Department of Rehabilitation Medicine, University of Colorado School of Medicine, Aurora, Colorado., Olson D; From the Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado.; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland., Lamb MM; Center for Global Health or Department of Epidemiology, Colorado School of Public Health, Aurora, Colorado., Paniagua-Avila A; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York City, New York., Anderson EJ; Emory University, Atlanta, Georgia., Focht C; Emmes Company, LLC, Rockville, Maryland., Colbert AM; Department of Rehabilitation Medicine, University of Colorado School of Medicine, Aurora, Colorado., Natrajan M; Emory University, Atlanta, Georgia., Waggoner JJ; Emory University, Atlanta, Georgia., Scherer E; Emory University, Atlanta, Georgia., Calvimontes DM; Fundacion para la Salud Integral de los Guatemaltecos, Retalhuleu, Guatemala., Bolaños GA; Fundacion para la Salud Integral de los Guatemaltecos, Retalhuleu, Guatemala., Bauer D; Fundacion para la Salud Integral de los Guatemaltecos, Retalhuleu, Guatemala., Arroyave P; Fundacion para la Salud Integral de los Guatemaltecos, Retalhuleu, Guatemala., Hernández S; Fundacion para la Salud Integral de los Guatemaltecos, Retalhuleu, Guatemala., Martinez MA; Fundacion para la Salud Integral de los Guatemaltecos, Retalhuleu, Guatemala., Ralda AV; Fundacion para la Salud Integral de los Guatemaltecos, Retalhuleu, Guatemala., Rojop N; Fundacion para la Salud Integral de los Guatemaltecos, Retalhuleu, Guatemala., Barrios EE; Fundacion para la Salud Integral de los Guatemaltecos, Retalhuleu, Guatemala., Chacon A; Fundacion para la Salud Integral de los Guatemaltecos, Retalhuleu, Guatemala., Dempsey W; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland., Tomashek KM; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland., Keitel WA; Department of Medicine, Baylor College of Medicine, Houston, Texas.; Department of Molecular Virology & Microbiology, Baylor College of Medicine, Houston, Texas., El Sahly HM; Department of Medicine, Baylor College of Medicine, Houston, Texas.; Department of Molecular Virology & Microbiology, Baylor College of Medicine, Houston, Texas., Muñoz FM; Department of Molecular Virology & Microbiology, Baylor College of Medicine, Houston, Texas.; Department of Pediatrics, Baylor College of Medicine, Texas. |
---|---|
Jazyk: | angličtina |
Zdroj: | The Pediatric infectious disease journal [Pediatr Infect Dis J] 2024 Dec 18. Date of Electronic Publication: 2024 Dec 18. |
DOI: | 10.1097/INF.0000000000004646 |
Abstrakt: | Background: Prenatal Zika virus (ZIKV) infection leads to microcephaly and adverse neurodevelopment. The effects of postnatal ZIKV infection on the developing brain are unknown. We assessed the neurodevelopmental outcomes of children exposed postnatally during the ZIKV epidemic. Methods: A prospective study enrolled infants 0-3 months of age and their mothers, and children 1.5-3.5 years of age in rural Guatemala from 2017 and were followed for 12 months until 2019. Neurodevelopment was evaluated using the Mullen Scales of Early Learning (MSEL). ZIKV and dengue virus (DENV) infections were identified by polymerase chain reaction (PCR) using active surveillance. Serological analyses, stratified by age group flavivirus serostatus at enrollment, were conducted using a focus reduction neutralization test. Results: Of 1371 enrolled participants, 1187 (86.6%) completed the study. No PCR-confirmed ZIKV infections were identified during the study period. One-third of 1.5-3.5-year-old children were ZIKV-seropositive at enrollment (likely postnatal infection). Twenty participants (5.8%) tested positive for DENV by PCR (11 infants, 5 children and 4 mothers); 15 (75%) were DENV-3 infections and 5 were DENV-2. The incidence of DENV infection in infants was 2.6%. No significant differences in MSEL scores were found between infants born seropositive versus seronegative for ZIKV or DENV. DENV seropositivity at enrollment in 1.5-5-year-old children was associated with lower MSEL scores for fine motor, visual reception and language, and microcephaly at 12 months versus seronegative children (all P < 0.05). Conclusions: Postnatal ZIKV infection in children from rural Guatemala was not associated with worse neurodevelopmental outcomes. DENV seropositivity was associated with a higher risk of microcephaly in infants and worse neurodevelopmental outcomes in children. Competing Interests: E.J.A. has served on safety monitoring and advisory boards for Moderna, Hillevax, Inovio, Sanofi and Merck, and his institution receives funds to conduct clinical research unrelated to this manuscript from Pfizer, Biofire, and Roche. F.M.M. has served on safety monitoring and advisory boards for Moderna, Pfizer, Sanofi, Aztra Zeneca and Merck and has conducted research funded by the US Centers for Disease Control and Prevention, Pfizer, Gilead. D.O. has received research support from Roche. Other authors have no conflicts of interest to disclose. (Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |